Could a new drug make gallbladder surgery recovery smoother?

NCT ID NCT07741188

Not yet recruiting Symptom relief Sponsor: Affiliated Hospital of Guangdong Medical University Source: ClinicalTrials.gov ↗

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial is testing whether an experimental drug called anrikefon can improve recovery and reduce pain after laparoscopic gallbladder removal, compared to a standard painkiller. Adults undergoing this surgery will receive either anrikefon or the standard drug, and their pain levels, sleep quality, and overall recovery will be tracked for 24 hours. The goal is to see if anrikefon offers better pain relief and a smoother recovery experience.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: anrikefon
What this could lead to: If it works, anrikefon could offer a new option for managing pain after gallbladder surgery, potentially improving recovery quality and reducing discomfort.
What could go wrong: This is an early-stage trial with a modest number of participants, so results may not be conclusive or apply to all patients. The drug may also have side effects, such as nausea or injection-site reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GALLBLADDER POLYPS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cholecystolithiasis gallstones polyp of gallbladder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GALLBLADDER POLYPS GALLBLADDER STONES

Contacts and locations

Locations

Affiliated Hospital of Guangdong Medical University

Zhanjiang, Guangdong, 524001, China
The Second Affiliated Hospital of Guangdong Medical University

Zhanjiang, Guangdong, 524001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.